You have read all your free articles, to continue reading subscribe to read the rest of this content.
Oslo Cancer Cluster recently named three winners in a competition seeking collaborative projects involving immuno-oncology. The three, BerGen Bio, Targovax and Ultimovacs each will receive MNOK 0,4 from Innovation Norway. BerGenBio will use the award to prove that Axl kinase inhibition may proAlready a subscriber Login You have read all your…
Taskén, who is director of the Biotechnology Centre and the Norwegian Centre for Molecular Medicine (NCMM), receives the award for his work with immunotherapy. He has contributed greatly to the understanding of immuno-oncology. Research that will be even more relevant in the development of next genAlready a subscriber Login You…
The prize is awarded to European women who have brought their scientific expertise to the market and founded an innovative company, in which they have benefited from the EU research and innovation funding. The second prize which was received by Jalkanen is €50,000. "Winning the second prize Already a subscriber…
Beactica, the Swedish fragment-based drug discovery company, announced that it has been awarded a SEK 3.0 million grant from the Swedish Governmental Agency for Innovation Systems (VINNOVA). The grant will be used to support the development of a new epigenetic drug for treatment of cancer. TheAlready a subscriber Login You have…
